VIB researchers flip the script by turning a disease feature into a unique new treatment modality that could tackle even the most undruggable targets.

Two early career researchers, two cutting-edge technology platforms. A double interview with Çagatay Aydin and Marie Mulier gives us a unique glimpse into the activity of the brain and how exciting it can be to push the limits and applications of emerging technologies to get there.